# A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants

> **NCT07133191** · PHASE1 · COMPLETED · sponsor: **Viatris Innovation GmbH** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **COMBINATION_PRODUCT:** Selatogrel
- **COMBINATION_PRODUCT:** Matching placebo

## Key facts

- **NCT ID:** NCT07133191
- **Lead sponsor:** Viatris Innovation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-07
- **Primary completion:** 2025-11-05
- **Final completion:** 2025-11-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07133191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07133191, "A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07133191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*